Partner Research Centers:
9 d32 b
c
Center for Neurodegenerative Disease Research
e
59
16
1a
19
1
49
2
18
1b
1d
18
32
5f
1d
2 29
1d
25
Virginia Man-Yee Lee
77
5f
John H. Ware 3rd Endowed Professor in Alzheimer's Research
28
bd
3
78
Director of Center for Neurodegenerative Disease Researach, Department of Pathology and Laboratory Medicine,University of Pennsylvania
11
Department: Pathology and Laboratory Medicine
4
1
b
1d
46
Contact information
5b
4
3
23
5b
Center for Neurodegenerative Disease Research
23 3rd Floor, Maloney Building
3a 3600 Spruce Street
Philadelphia, PA 19104-4283
26
23 3rd Floor, Maloney Building
3a 3600 Spruce Street
Philadelphia, PA 19104-4283
30
Office: (215) 662-6427
34 Fax: (215) 349-5909
32 Lab: 215-662-3292
18
81
34 Fax: (215) 349-5909
32 Lab: 215-662-3292
18
Email:
VMYLEE@UPENN.EDU
12
VMYLEE@UPENN.EDU
1f
Graduate Group Affiliations
8
a
3
1d
18
Publications
23 a
3
2
4
b
1f
23 a
13
Education:
21 5 c
40 Royal Academy of Music, London, England, 1964.
21 9 B.Sc 16 (Chemistry) c
31 Univ. of London, England, 1967.
21 9 M.Sc 19 (Biochemistry) c
31 Univ. of London, England, 1968.
21 a Ph.D. 19 (Biochemistry) c
42 University of California at San Francisco, 1973.
21 b M.B.A. c
51 Wharton School, University of Pennsylvania, Philadelphia, 1984.
c
3
27
21 5 c
40 Royal Academy of Music, London, England, 1964.
21 9 B.Sc 16 (Chemistry) c
31 Univ. of London, England, 1967.
21 9 M.Sc 19 (Biochemistry) c
31 Univ. of London, England, 1968.
21 a Ph.D. 19 (Biochemistry) c
42 University of California at San Francisco, 1973.
21 b M.B.A. c
51 Wharton School, University of Pennsylvania, Philadelphia, 1984.
c
Links
95 Search PubMed for articles
5f Primary Work Website
51 Biochemistry and Molecular Biophysics graduate group faculty webpage.
3c Neuroscience graduate group faculty webpage.
43 Cell and Molecular Biology graduate group faculty webpage.
3e Pharmacological Sciences graduate group faculty webpage.
c
5
21
95 Search PubMed for articles
5f Primary Work Website
51 Biochemistry and Molecular Biophysics graduate group faculty webpage.
3c Neuroscience graduate group faculty webpage.
43 Cell and Molecular Biology graduate group faculty webpage.
3e Pharmacological Sciences graduate group faculty webpage.
c
1f
Post-Graduate Training
24 77 Rudolf Magnus Institute for Pharmacology, University of Utrecht, Utrecht, The Netherlands, 1973-1974.
24 80 Dept. of Neuropathology, Children's Hospital Medical Center and Harvard Medical School, Boston, MA, 1974-1979.
c
3
3
90
Permanent link24 77 Rudolf Magnus Institute for Pharmacology, University of Utrecht, Utrecht, The Netherlands, 1973-1974.
24 80 Dept. of Neuropathology, Children's Hospital Medical Center and Harvard Medical School, Boston, MA, 1974-1979.
c
2 29
21
1e
1d
24
5e
6e Biology of tau, synucleins, TDP-43 and amyloid beta precursor proteins (APPs) in health and disease.
8
c4 Key words: Alzheimer's disease; tauopathies; APP; Parkinson’s disease; synucleinopathies, amyotrophic lateral sclerosis, Frontotemporal lobar degeneration, TDP-43 proteinopathies.
8
26 Description of Research
3a2 Dr. Lee’s research focuses on disease proteins that form pathological inclusions in hereditary and sporadic Alzheimer’s disease (AD), Parkinson’s disease (PD), frontotemporal lobar degeneration (FTLD), amyotrophic lateral sclerosis (ALS) and related neurodegenerative disorders of aging. Her work demonstrated that tau, alpha-synuclein and TDP-43 proteins form unique brain aggregates in neurodegenerative diseases and provided critical evidence that aggregation of brain proteins is a common mechanistic theme in diverse neurodegenerative diseases including AD, PD, FTLD, ALS and related disorders. Significantly, Dr. Lee’s studies implicated the abnormal aggregation of tau, alpha-synuclein and TDP-43 in mechanisms that compromise neuronal viability. Most importantly, this research has opened up new avenues of research to identify targets for drug discovery to develop better treatments for these disorders.
8
22 Research Techniques
cd Protein biochemistry; cell and molecular biology; monoclonal antibody production; immunochemical and immunocytochemical techniques; tissue culture; transgenic mouse models; and electron microscopy.
8
20 Rotation Projects
8d Lab rotation projects are difficult to define in a rapidly moving field. Please contact Dr. Lee to discuss possible rotation projects.
26 29
27
Description of Research Expertise
2b Research Interests6e Biology of tau, synucleins, TDP-43 and amyloid beta precursor proteins (APPs) in health and disease.
8
c4 Key words: Alzheimer's disease; tauopathies; APP; Parkinson’s disease; synucleinopathies, amyotrophic lateral sclerosis, Frontotemporal lobar degeneration, TDP-43 proteinopathies.
8
26 Description of Research
3a2 Dr. Lee’s research focuses on disease proteins that form pathological inclusions in hereditary and sporadic Alzheimer’s disease (AD), Parkinson’s disease (PD), frontotemporal lobar degeneration (FTLD), amyotrophic lateral sclerosis (ALS) and related neurodegenerative disorders of aging. Her work demonstrated that tau, alpha-synuclein and TDP-43 proteins form unique brain aggregates in neurodegenerative diseases and provided critical evidence that aggregation of brain proteins is a common mechanistic theme in diverse neurodegenerative diseases including AD, PD, FTLD, ALS and related disorders. Significantly, Dr. Lee’s studies implicated the abnormal aggregation of tau, alpha-synuclein and TDP-43 in mechanisms that compromise neuronal viability. Most importantly, this research has opened up new avenues of research to identify targets for drug discovery to develop better treatments for these disorders.
8
22 Research Techniques
cd Protein biochemistry; cell and molecular biology; monoclonal antibody production; immunochemical and immunocytochemical techniques; tissue culture; transgenic mouse models; and electron microscopy.
8
20 Rotation Projects
8d Lab rotation projects are difficult to define in a rapidly moving field. Please contact Dr. Lee to discuss possible rotation projects.
26 29
23
148 Goosens J, Vanmechelen E, Trojanowski JW, Lee VM, Van Broeckhoven C, van der Zee J, Engelborghs S. : TDP-43 as a possible biomarkers for frontotemporal lobar degeneration: a systematic review of existing antibodies. Acta Neuropathol Commun. 3: 15, 2015.
f4 Porta S, Kwong LK, Trojanowski JQ, Lee VM: Drosha Inclusions Are New Components of Dipeptide-Repeat Protein Aggregates in FTLD-TDP and ALS C9orf72 Expansion Cases. J Neuropathol Exp Neurol 27 74: 380-387, 2015.
f7 Brettschneider J, Del Tredici K, Lee VM, Trojanowski JQ.: Spreading of pathology in neurodegenerative diseases: a focus on human studies. Nat Rev Neurosci 16: 109-120, 2015.
14b Ballatore C, Gay B, Huang L, Robinson KH, James MJ, Trojanowski JQ, Lee VM-Y, Brunden KR, Smith AB 3rd. : Evaluation of the cyclopentane-1,2-dione as a potential bio-isostere of the carboxylic acid functional group. Bioorg Med Chem Lett 24: 4171-4175, 2014.
143 Crescenzi R, DeBrosse C, Nanga RP, Reddy S, Haris M, Hariharan H, Iba M, Lee VM-Y, Detre JA, Borthakur A, Reddy R. : In vivo measurement of glutamate loss is associated with synapse loss in a mouse model of tauopathy. Neuroimage 101C: 185-192, 2014.
1b5 Peeraer E, Bottelvergs A, Van Kolen K, Mahieu M, Duyschaever H, Verdonck L, Torremans A, Sluydts E, Van Acker N, Kemp JA, Brunden KR, Trojanowski JQ, Dewachter I, Lee VM-Y, Moechars D. : Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice. Neurobiol Dis 73: 83-95, 2014.
121 Boluda S, Toledo JB, Irwin DJ, Raible KM, Byrne MD, Lee EB, Lee VM-Y, Trojanowski JQ: A comparison of Aβ amyloid pathology staging systems and correlation with clinical diagnosis. Acta Neuropath 128: 543-550, 2014.
114 Ballatore C, Smith AB 3rd, Lee VM-Y, Trojanowski JQ, Brunden KR. : Aminothienopyridazines as imaging probes of tau pathology: a patent evaluation of WO2013090497. Expert Opin Ther Pat 24: 355-360, 2014.
122 Tran HT, Chung CH, Luk KC, Iba M, Zhang B, Trojanowski JQ, Lee VM-Y. : α-Synuclein immunotherapy blocks uptake and templated propagation of misfolded α-Synuclein and neurodegeneration. Cell Reports 72: 1-12, 2014.
2c
7
1d
1f
Selected Publications
f3 Cohen TJ, Hwang AW, Restrepo C, Yuan CX, Trojanowski JQ, Lee VM-Y. : An acetylation switch controls TDP-43 function and aggregation propensity. Nat Commun 6: 5845, 2015.148 Goosens J, Vanmechelen E, Trojanowski JW, Lee VM, Van Broeckhoven C, van der Zee J, Engelborghs S. : TDP-43 as a possible biomarkers for frontotemporal lobar degeneration: a systematic review of existing antibodies. Acta Neuropathol Commun. 3: 15, 2015.
f4 Porta S, Kwong LK, Trojanowski JQ, Lee VM: Drosha Inclusions Are New Components of Dipeptide-Repeat Protein Aggregates in FTLD-TDP and ALS C9orf72 Expansion Cases. J Neuropathol Exp Neurol 27 74: 380-387, 2015.
f7 Brettschneider J, Del Tredici K, Lee VM, Trojanowski JQ.: Spreading of pathology in neurodegenerative diseases: a focus on human studies. Nat Rev Neurosci 16: 109-120, 2015.
14b Ballatore C, Gay B, Huang L, Robinson KH, James MJ, Trojanowski JQ, Lee VM-Y, Brunden KR, Smith AB 3rd. : Evaluation of the cyclopentane-1,2-dione as a potential bio-isostere of the carboxylic acid functional group. Bioorg Med Chem Lett 24: 4171-4175, 2014.
143 Crescenzi R, DeBrosse C, Nanga RP, Reddy S, Haris M, Hariharan H, Iba M, Lee VM-Y, Detre JA, Borthakur A, Reddy R. : In vivo measurement of glutamate loss is associated with synapse loss in a mouse model of tauopathy. Neuroimage 101C: 185-192, 2014.
1b5 Peeraer E, Bottelvergs A, Van Kolen K, Mahieu M, Duyschaever H, Verdonck L, Torremans A, Sluydts E, Van Acker N, Kemp JA, Brunden KR, Trojanowski JQ, Dewachter I, Lee VM-Y, Moechars D. : Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice. Neurobiol Dis 73: 83-95, 2014.
121 Boluda S, Toledo JB, Irwin DJ, Raible KM, Byrne MD, Lee EB, Lee VM-Y, Trojanowski JQ: A comparison of Aβ amyloid pathology staging systems and correlation with clinical diagnosis. Acta Neuropath 128: 543-550, 2014.
114 Ballatore C, Smith AB 3rd, Lee VM-Y, Trojanowski JQ, Brunden KR. : Aminothienopyridazines as imaging probes of tau pathology: a patent evaluation of WO2013090497. Expert Opin Ther Pat 24: 355-360, 2014.
122 Tran HT, Chung CH, Luk KC, Iba M, Zhang B, Trojanowski JQ, Lee VM-Y. : α-Synuclein immunotherapy blocks uptake and templated propagation of misfolded α-Synuclein and neurodegeneration. Cell Reports 72: 1-12, 2014.
2c
19
50
Back to Top
17
8
2
f
8
© The Trustees of the University of Pennsylvania | Site best viewed in a supported browser. | Site Design: PMACS Web Team. 6
c